These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Clinical and immunological reactions after measles vaccination with cleavage vaccine and live vaccine]. Stehr K; Enders G; Suschke HJ; Spiess H Monatsschr Kinderheilkd (1902); 1970 Jun; 118(6):383-7. PubMed ID: 5523685 [No Abstract] [Full Text] [Related]
7. [Neurologic disorders after vaccination against measles and mumps]. Skovránková J; Komárek V; Domorázková E Cesk Pediatr; 1992 Jun; 47(6):343-5. PubMed ID: 1525918 [TBL] [Abstract][Full Text] [Related]
8. Measles vaccination and risk of SSPE. Agarwal RK Indian Pediatr; 1999 Mar; 36(3):317. PubMed ID: 10713848 [No Abstract] [Full Text] [Related]
9. [Epidemic problems of measles and mumps inoculation]. Allerdist H Offentl Gesundheitswes; 1979 Sep; 41 Suppl 1():51-6. PubMed ID: 161394 [No Abstract] [Full Text] [Related]
10. [Influence of measles vaccination using the live measles virus vaccine SSW-L 16 on the complication rate in measles]. Heidel G; Olbricht H; Ely K; Henkler J Z Arztl Fortbild (Jena); 1972 Feb; 66(3):171-4. PubMed ID: 5047088 [No Abstract] [Full Text] [Related]
11. [Immunologic response and post-vaccination reactions in children vaccinated against measles. I. Assessment of post-vaccination reactions]. Naruszewicz-Lesiuk D; Kańtoch M; Polna I Przegl Epidemiol; 1974; 28(3):315-24. PubMed ID: 4471837 [No Abstract] [Full Text] [Related]
12. [Repercussions of vaccination against measles]. Guerrero EV; Calderón C; Velázquez Franco E Salud Publica Mex; 1974; 16(5):707-20. PubMed ID: 4456647 [No Abstract] [Full Text] [Related]
13. Live measles vaccine prepared in dog kidney cells. 3. Vaccination against measles with Czechoslovak live vaccine. Adam E; Kratochvílova M; Mares I; Drevo M; Závadová H J Hyg Epidemiol Microbiol Immunol; 1966; 10(2):232-9. PubMed ID: 5330077 [No Abstract] [Full Text] [Related]
14. [Indications and contraindications for the measles vaccination of children with an aggravated neurological anamnesis]. Kossova ET; Dadiomova MA; Lakotkina EA; Ryzhova TP Tr Inst Im Pastera; 1979; 53():40-3. PubMed ID: 262710 [No Abstract] [Full Text] [Related]
15. [Measles vaccination in children with brain damage]. Hempel HC; Grimm J Dtsch Gesundheitsw; 1968 Oct; 23(44):2106-7. PubMed ID: 5730922 [No Abstract] [Full Text] [Related]
16. [Measles vaccination in Norway]. Tidsskr Nor Laegeforen; 1976 Oct; 96(29):1533-5. PubMed ID: 982382 [No Abstract] [Full Text] [Related]
17. [Trendobservation of beneficial effects of vaccinations (author's transl)]. Ambrosch F; Wiedermann G; Kundi M Zentralbl Bakteriol Orig A; 1977 Dec; 239(4):541-7. PubMed ID: 610249 [TBL] [Abstract][Full Text] [Related]
19. Assessment: Neurologic risk of immunization: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Fenichel GM Neurology; 1999 May; 52(8):1546-52. PubMed ID: 10331677 [No Abstract] [Full Text] [Related]
20. [Atypical measles following immunization with inactivated measles vaccine (split vaccine)]. Hagge W; Enders-Ruckle G; von Brenndorff AI Monatsschr Kinderheilkd (1902); 1974 Jul; 122(7):504-6. PubMed ID: 4408628 [No Abstract] [Full Text] [Related] [Next] [New Search]